PHARMLOGIC GROUP LIMITED
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Summary
PHARMLOGIC GROUP LIMITED is an active private limited company (company number 15344359) incorporated on 11 December 2023, registered in London. Its registered activity is business and domestic software development (SIC 62012). Accounts are on file at Companies House (micro entity) but not yet parsed into this record.
There are 15,170 companies in business and domestic software development in London with filed accounts; the median reports net assets of £702 and is 5 years old.
Key dates
- Incorporated
- 11 December 20232 yrs ago
- First accounts due
- 11 September 2025406 days overdue
- Confirmation statement due
- 25 December 2026in 64 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 62012
- Business and domestic software development
- Accounts type
- Micro Entity
Financials
Accounts exist on the register but their figures are not in this dataset yet.
Filing and accounts signals
- Incorporated two to five years agoIncorporated 11 December 2023
- Accounts past their due dateDue 11 September 2025
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Ownership and control
- Mr Arvin Abdollahzadeh
- owns 75–100% of shares
- holds 75–100% of voting rights
- Mr Louis James Tromans
- owns 25–50% of shares
- Mr Yousif Abass
- owns 25–50% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Timeline
- Confirmation statement duein 64 days
- First accounts due406 days overdue
- Incorporated
Similar companies in London
Reminders for PHARMLOGIC GROUP LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.